NCT00783133View on ClinicalTrials.gov

Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177)

PHASE4CompletedINTERVENTIONAL

Enrollment

131

Participants

Timeline

Start Date

November 1, 2002

Primary Completion Date

June 1, 2003

Study Completion Date

June 1, 2003

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Desloratadine 5 mg

Clarinex 5 mg daily x 7 days

DRUG

fexofenadine

Allegra 180 mg daily x 7 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00783133 - Preference for Clarinex Tablets vs. Allegra Tablets in Patients With Seasonal Allergies (Study P03177) | Biotech Hunter | Biotech Hunter